Rigel Pharmaceuticals Inc (RIGL): EPS (Diluted)
$19.48
Year ended 2025-12-31
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $19.48 | n/m | 2026-03-03, From 2025-01-01 |
| 2024-12-31 | $0.99 | n/m | 2026-03-03, From 2024-01-01 |
| 2023-12-31 | -$1.44 | n/m | 2026-03-03, From 2023-01-01 |
| 2022-12-31 | -$3.44 | n/c | 2025-03-04, From 2022-01-01 |
| 2021-12-31 | -$0.11 | n/m | 2024-03-05, From 2021-01-01 |
| 2020-12-31 | -$0.18 | n/m | 2023-03-07, From 2020-01-01 |
| 2019-12-31 | -$0.40 | n/a | 2022-03-01, From 2019-01-01 |
| No annual figure between 2012-12-31 and 2019-12-31. | |||
| 2012-12-31 | -$1.32 | n/m | 2013-03-05, From 2012-01-01 |
| 2011-12-31 | -$1.36 | n/m | 2013-03-05, From 2011-01-01 |
| 2010-12-31 | $0.72 | n/m | 2013-03-05, From 2010-01-01 |
| 2009-12-31 | -$2.73 | n/a | 2012-03-06, From 2009-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Rigel Pharmaceuticals Inc (RIGL) | 2025-12-31 | $19.48 | n/m |
| Rapport Therapeutics, Inc. (RAPP) | 2025-12-31 | -$2.86 | n/m |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | -$0.26 | n/m |
| Syndax Pharmaceuticals Inc (SNDX) | 2025-12-31 | -$3.29 | n/m |
| Dianthus Therapeutics, Inc. (DNTH) | 2025-12-31 | -$4.20 | n/m |
| Olema Pharmaceuticals, Inc. (OLMA) | 2025-12-31 | -$1.87 | n/m |
| Vanda Pharmaceuticals Inc. (VNDA) | 2025-12-31 | -$3.74 | n/m |
| Rhythm Pharmaceuticals, Inc. (RYTM) | 2025-12-31 | -$3.11 | n/m |
| MapLight Therapeutics, Inc. (MPLT) | 2025-12-31 | -$18.56 | n/m |
Compare RIGL, RAPP, ARDX, SNDX side by side · Screen every company in Pharmaceutical Preparations ↗